Skip to main content
AmigoFish

Ep. 77 - AI’s Next Leap: Foresite Labs’ Vik Bajaj on Predictive Biology

From The BioCentury Show · · 35 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Clinical trials will be launched in the next year or two to test predictions about causal biology made by artificial intelligence models, Vik Bajaj, co-founder and CEO of Foresite Labs and managing director of Foresite Capital Management, believes. Foresite teamed up with Arch Venture Partners last year on a $1 billion venture round to fund Xaira Therapeutics, which aims to reinvent the R&D process via AI-driven protein design and biological discovery technologies (https://www.biocentury.com/article/652304). Bajaj, who serves as interim president of Xaira, discussed the potential for artificial intelligence to accelerate biomedical progress in an interview with Washington Editor Steve Usdin on The BioCentury Show.

View full story: https://www.biocentury.com/article/654977

#biotech #biopharma #pharma #lifescience #AI #RandD #drugdiscovery

00:00 - Introduction 01:18 - AI & Biotech 12:19 - Getting the Data Right 19:06 - Healthcare Delivery 30:47 - Making It Real

Back to The BioCentury Show · Report a problem